The lipids of Pneumocystis carinii

Clinical Microbiology Reviews

Volumn 11, Issue 1, 1998, Pages 27-41

  Kaneshiro, Edna S ^a  

^a UNIVERSITY OF CINCINNATI   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIPROTOZOAL AGENT; ATOVAQUONE; FATTY ACID; ISOPRENOID; LIPID; LIPOXYGENASE; LUNG SURFACTANT; NAPHTHOQUINONE; PHOSPHOLIPASE; PHOSPHOLIPID; PROTEIN; SPHINGOLIPID; UBIDECARENONE; UBIQUINONE DERIVATIVE;

ALKYLATION; CRYPTOSPORIDIUM; DRUG ACTIVITY; DRUG SYNTHESIS; ENZYME ACTIVITY; ENZYME INHIBITION; HUMAN; ISOTOPE LABELING; LIPID COMPOSITION; LIPID METABOLISM; LIPOGENESIS; LUNG LAVAGE; MICROSPORUM; NONHUMAN; PNEUMOCYSTIS CARINII; PNEUMOCYSTIS PNEUMONIA; RESPIRATORY CHAIN; REVIEW; TOXOPLASMA;

CRYPTOSPORIDIUM; MICROSPORIDIA; MICROSPORUM; PNEUMOCYSTIS CARINII; PROTISTA; PROTOZOA; TOXOPLASMA;

EID: 0031964015     PISSN: 08938512     EISSN: None     Source Type: Journal    
DOI: 10.1128/cmr.11.1.27     Document Type: Review

References (117)

1. Alexopoulos, C. J., C. W. Mims, and M. Blackwell. 1996. Introductory mycology, 4th ed., p. 258-271. John Wiley & Sons, Inc., New York, N.Y.
2. Amit, Z., and E. S. Kaneshiro. Unpublished data.
3. Banerji, S., A. E. Wakefield, A. G. Allen, D. J. Maskell, S. E. Peters, and J. M. Hopkin. 1993. The cloning and characterization of the arom gene of Pneumocystis carinii. J. Gen. Microbiol. 139:2901-2914.
4. Baughman, R. P., W. Hyull, and J. A. Whitsett. 1992. Pneumocystis carinii alters surfactant associated protein-A concentrations found in bronchoalveolar lavage fluid. Clin. Res. 40:412A.
5. Baughman, R. P., R. I. Sternberg, W. Hull, J. Buchsbaum, and J. Whitsett. 1993. Decreased surfactant protein A in patients with bacterial pneumonia. Am. Rev. Respir. Dis. 147:653-657.
6. Boylan, C. J., and W. L. Current. 1992. Improved model of Pneumocystis carinii pneumonia: induced laboratory infection in Pneumocystis-free animals. Infect. Immun. 60:1589-1597.
7. Cantin, A. M., S. L. North, R. L. Hubbard, and R. G. Crystal. 1987. Normal alveolar epithlia fluid contains high levels of glutathione. J. Appl. Physiol. 63:152-157.
8. Casey, P. J. 1995. Protein lipidation in cell signaling. Science 268:221-225.
9. Castro, M., T. I. Morgenthaler, O. A. Hoffman, J. E. Standing, M. S. Rohrbach, and A. H. Limper. 1993. Pneumocystis carinii induces the release of arachidonic acid and its metabolites from alveolar macrophages. Am. J. Respir. Cell Mol. Biol. 9:73-81.
10. Chen, F., and M. T. Cushion. 1994. Use of an ATP bioluminescent assay to evaluate viability of Pneumocystis carinii from rats. J. Clin. Microbiol. 32: 2791-2800.
11. Chin, K., S. Merali, M. M. Shaw, M. S. Bartlett, and A. B. Clarkson, Jr. 1996. Subpopulations of Pneumocystis carinii separated by a Percoll gradient. J. Eukaryot. Microbiol. 43:53S.
12. Contini, C., M. Manganaro, R. Romani, S. Tzatzoglou, I. Poggesi, V. Vullo, S. Delia, and C. De Simone. 1994. Activity of terbinafine against Pneumocystis carinii in vitro and its efficacy in the treatment of experimental pneumonia. J. Antimicrob. Agents Chemother. 34:727-735.
13. Cushion, M. T. 1989. In vitro studies of Pneumocystis carinii. J. Protozool. 36:45-52.
14. Cushion, M. T. Personal communication.
15. De Stefano, J. A., M. T. Cushion, R. G. Sleight, and P. D. Walzer. 1990. Analysis of Pneumocystis carinii cyst wall. I. Evidence for an outer surface membrane. J. Protozool. 37:428-435.
16. De Stefano, J. A., M. T. Cushion, V. Puvanesarajah, and P. D. Walzer. 1990. Analysis of Pneumocystis carinii cyst wall. II. Sugar composition. J. Protozool. 37:436-441.
17. De Stefano, J. A., R. G. Sleight, G. F. Babcock, R. M. Sramkoski, and P. D. Walzer. 1992. Isolation of Pneumocystis carinii cysts by flow cytometry. Parasitol. Res. 78:179-182.
18. De Stefano, J. A., J. M. Foy, D. W. Sullivan, S. M. Dawes, M. T. Cushion, G. F. Babcock, R. G. Sleight, H. van Halbeek, and P. D. Walzer. 1994. Fractionation of Pneumocystis carinii developmental stages by counterflow centrifugal elutriation and sequential filtrations. Parasitol. Res. 80:1-9.
19. Dohn, M. N., P. T. Frame, R. P. Baughman, S. W. Lafon, A. G. Smulian, P. Caldwell, and M. D. Rogers. 1992. Open-label efficacy and safety trial of 42 days of 566C80 for Pneumocystis carinii pneumonia in AIDS patients. J. Eukaryot. Microbiol. 38:220S-221S.
20. Edman, J. C., J. A. Kovacs, H. Masur, D. Santi, H. J. Harwood, and M. L. Sogin. 1988. Ribosomal RNA sequence shows Pneumocystis carinii to be a member of the fungi. Nature (London) 334:519-522.
21. Ellis, J. E. 1994. Coenzyme Q homologs in parasitic protozoa as targets for chemotherapeutic attack. Parasitol. Today 10:296-301.
22. Ellis, J. E., M. H. Reilly, and E. S. Kaneshiro. 1994. Identification of an epoxy fatty acid in Pneumocystis carinii lipids. J. Eukaryot. Microbiol. 41: 87S.
23. 10 as the major ubiquinone homolog. J. Eukaryot. Microbiol. 43:165-170.
24. Florin-Christensen, M., J. Florin-Christensen, Y.-P. Wu, L. Zhou, A. Gupta, H. Rudney, and E. S. Kaneshiro. 1994. Occurrence of specific sterols in Pneumocystis carinii. Biochem. Biophys. Res. Commun. 198:236-242.
25. Florin-Christensen, M., J. Florin-Christensen, and E. S. Kaneshiro. 1995. Uptake and metabolism of L-serine by Pneumocystis carinii carinii. J. Eukaryot. Microbiol. 42:669-675.
26. Furlong, S. T., J. A. Samia, R. M. Rose, and J. A. Fishman. 1994. Phytosterols are present in Pneumocystis carinii. Antimicrob. Agents Chemother. 38:2534-2540.
27. Furlong, S. T., D. E. Frederique, N. Ghildyal, M. M. Shaw, M. S. Bartlett, G. L. McLaughlin. 1996. Evidence for a lipophosphoglycan from Pneumocystis carinii, abstr. 173, p. 126. In Abstracts of the Joint Meeting of the American Society of Parasitology and the Society of Protozoologists, 1996.
28. Furlong, S. T., H. Koziel, M. S. Bartlett, G. L. McLaughlin, M. M. Shaw, and R. M. Jack. 1997. Lipid transfer from human epithelial cells to Pneumocystis carinii in vitro. J. Infect. Dis. 175:661-668.
29. Gigliotti, F., A. G. Harmsen, C. G. Haidaris, and P. J. Haidaris. 1993. Pneumocystis carinii is not universally transmissable between mammalian species, Infect. Immun. 61:2886-2890.
30. Goheen, M. P., M. S. Bartlett, M. M. Shaw, S. F. Queener, and J. W. Smith. 1993. Effects of 8-aminoquinolines on the ultrastructural morphology of Pneumocystis carinii. Int. J. Exp. Pathol. 74:379-387.
31. Graves, D. C., S. J. N. McNabb, M. H. Ivey, and M. A. Worley. 1986. Development and characterization of monoclonal antibodies to Pneumocystis carinii. Infect. Immun. 51:125-133.
32. Guo, Z., and E. S. Kaneshiro. 1994. The composition of Pneumocystis carinii phospholipids. J. Eukaryot. Microbiol. 41:90S.
33. Guo, Z., and E. S. Kaneshiro. 1995. Phospholipid composition of Pneumocystis carinii carinii and effects of methylprednisolone immunosuppression on rat lung lipids. Infect. Immun. 63:1286-1290.
34. Guo, Z., D. H. Beach, and E. S. Kaneshiro. 1996. Fatty acid composition of the major phospholipids of Pneumocystis carinii carinii: comparison with those in the lungs of normal and methylprednisolone-immunosuppressed rats. Infect. Immun. 64:1407-1412.
35. Gutteridge, W. E. 1991. Pneumocystis carinii: potential targets for chemotherapeutic attack, p. 35-51. In G. H. Coombs and M. J. North (ed.), Biochemical protozoology. Taylor & Francis, London, United Kingdom.
36. Hannun, Y. A. 1996. Functions of ceramide in coordinating cellular responses to stress. Science 274:1855-1859.
37. Haughan, P. A., and J. L. Goad. 1991. Lipid biochemistry of trypanosomatids, p. 312-328. In G. H. Coombs and M. J. North (ed.), Biochemical protozoology. Taylor & Francis, London, United Kingdom.
38. Hoffman, A. G. D., M. G. Lawrence, F. P. Ognibene, A. F. Suffredini, G. Y. Lipschik, J. A. Kovacs, H. Masur, and J. H. Shelhamer. 1992. Reduction of pulmonary surfactant in patients with human immunodeficiency virus infection and Pneumocystis carinii pneumonia. Chest 102:1730-1738.
39. Hughes, W. T., V. L. Gray, W. E. Gutteridge, V. S. Latter, and M. Pudney. 1990. Efficacy of a hydroxynapthoquinone, 566C80, in experimental parasitic infections of AIDS pneumonitis. Antimicrob. Agents Chemother. 34: 225-228.
40. Ittarat, I., W. Asawamahasakda, and S. R. Meshnick. 1994. A preliminary characterization of the Pneumocystis carinii dihydroorotate dehydrogenase. J. Eukaryot. Microbiol. 41:92S.
41. Ittarat, I., W. Asawamahasakda, M. S. Bartlett, J. W. Smith, and S. R. Meshnick. 1995. Effects of atovaquone and other inhibitors on Pneumocystis carinii dihydroorotate dehydrogenase. Antimicrob. Agents Chemother. 39:325-328.
42. Leu99→Pro that produces temperature sensitive myristic acid auxotrophy. J. Biol. Chem. 268:483-494.
43. Kallam, K. A., and E. S. Kaneshiro. 1996. Detailed analyses of individual neutral lipid classes of Pneumocystis. J. Eukaryot. Microbiol. 43:51S.
44. Kaneshiro, E. S. Unpublished data.
45. Kaneshiro, E. S., and R. G. Sleight. 1993. Biochemistry and metabolism, p. 45-71. In P. D. Walzer (ed.), Pneumocystis carinii pneumonia, 2nd ed. Marcel Dekker, Inc., New York, N.Y.
46. Kaneshiro, E. S., and M. A. Wyder. 1993. Lipophosphoglycan antigen shedding by Leishmania donovani. J. Eukaryot. Microbiol. 40:336-340.
47. Kaneshiro, E. S., K. Jayasimhulu, and R. L. Lester. 1986. Characterizations of inositol lipids from Leishmania donovani promastigotes: identification of an inositol sphingolipid. J. Lipid Res. 27:1294-1303.
48. Kaneshiro, E. S., M. T. Cushion, P. D. Walzer, and K. Jayasimhulu. 1989. Analysis of Pneumocystis fatty acids. J. Protozool. 36:69S-72S.
49. Kaneshiro, E. S., Y.-P. Wu, and M. T. Cushion. 1991. Assays for testing Pneumocystis carinii viability. J. Protozool. 38:85S-87S.
50. Kaneshiro, E. S., M. A. Wyder, Y.-P. Wu, and M. T. Cushion. 1993. Reliability of calcein methoxy methyl ester and ethidium homodimer or propidium iodide for viability assessment of microbes. J. Microbiol. Methods. 17:1-16.
51. Kaneshiro, E. S., M. A. Wyder, L. H. Zhou, J. E. Ellis, D. R. Voelker, and S. G. Langreth. 1993. Characterization of Pneumocystis carinii preparations developed for lipid analysis. J. Eukaryot. Microbiol. 40:805-815.
52. Kaneshiro, E. S., J. E. Ellis, K. Jayasimhulu, and D. H. Beach. 1994. Evidence for the presence of "metabolic sterols" in Pneumocystis: identification and initial characterization of Pneumocystis carinii sterols. J. Eukaryot. Microbiol. 41:78-85.
53. Kaneshiro, E. S., J. E. Ellis, L. H. Zhou, H. Rudney, A. Gupta, K. Jayasimhulu, K. D. R. Setchell, and D. H. Beach. 1995. Isoprenoid metabolism in Pneumocystis carinii. J. Eukaryot. Microbiol. 41:93S.
54. Kaneshiro, E. S., J. E. Ellis, Z. Guo, K. Jayasimhulu, J. N. Maiorano, and K. A. Kallam. 1996. Characterizations of neutral lipid fatty acids and cis-9,10-epoxy octadecanoic acid in Pneumocystis carinii carinii. Infect. Immun. 64:4105-4114.
55. 32 sterols in Pneumocystis carinii hominis-infected human lungs. J. Eukaryot. Microbiol. 43:365.
56. Kaneshiro, E. S., Z. Guo, D. Sul, K. A. Kallam, K. Jayasimhulu, and D. H. Beach. The fatty alcohols and ether lipids of Pneumocystis carinii carinii. Unpublished data.
57. Kaneshiro, E. S., K. Jayasimhulu, and J. De Stefano. Lipid modification of Pneumocystis carinii major surface antigen. Unpublished data.
58. Kernbaum, S., U. Masliah, L. G. Alcindor, C. Bouton, and D. Cristol. 1983. Phospholipase activities of bronchoalveolar lavage fluid in rat Pneumocystis carinii pneumonia. Br. J. Exp. Pathol. 64:75-80.
59. Korn, E. D., D. G. Dearborn, and P. L. Wright. 1974. Lipophosphonoglycan of the plasma membrane of Acanthamoeba castellanii. Isolation from whole amoebae and identification of the water-soluble products of acid hydrolysis. J. Biol. Chem. 249:3335-3341.
60. Langreth, S. G., and E. S. Kaneshiro. 1993. Pathogenesis of Pneumocystis carinii pneumonia in viral-negative immunosuppressed rats, an ultrastructural study, p. 70. In Abstracts of the 9th International Congress of Protozoology 1993.
61. Lee, C.-H., N. L. Bauer, M. M. Shaw, M. M. Durkin, M. S. Bartlett, S. F. Queener, and J. W. Smith. 1993. Proliferation of rat Pneumocystis carinii on cells sheeted on microcarrier beads in spinner flasks. J. Clin. Microbiol. 31:1659-1662.
62. Li, J., and T. Edlind. 1994. Phylogeny of Pneumocystis carinii based on beta-tubulin sequence. J. Eukaryot. Microbiol. 41:97S.
63. Limper, A. H., and W. J. Martin II. 1990. Pneumocystis carinii: inhibition of lung cell growth mediated by parasite attachment. J. Clin. Invest. 85:391-396.
64. Limper, A. H., J. E. Standing, O. A. Hoffman, M. Castro, and L. W. Neese. 1993. Vitronectin binds to Pneumocystis carinii and mediates organism attachment to cultured lung epithelial cells. Infect. Immun. 61:4302-4309.
65. Limper, A. H., D. M. O'Riordan, Z. Vuk-Pavlovic, and E. C. Crouch. 1994. Accumulation of surfactant protein D in the lung during Pneumocystis carinii pneumonia. J. Eukaryot. Microbiol. 41:98S.
66. Masala, C., M. Sorice, M. A. DiPrima, L. Lenti, R. Misasi, C. Contini, and V. Vullo. 1989. Anticardiolipin antibodies and Pneumocystis carinii pneumonia. Ann. Intern. Med. 110:749.
67. Masala, C., M. Sorice, M. A. Di Prima, L. Lenti, R. Misasi, M. Mojon, C. Contini, and V. Vullo. 1989. Evidence for shared epitopes between cardiolipin and Pneumocystis carinii. J. Infect. Dis. 160:736-737.
68. Mehta, M., and E. S. Kaneshiro. Unpublished data.
69. Merrill, H. A., Jr., G. van Echten, E. Wang, and K. Sandhoff. 1993. Fumonisin B1 inhibits sphingosinc (sphinganine) N-acyltransferase and de novo sphingolipid biosynthesis in cultured neurons in situ. J. Biol. Chem. 268: 27299-27306.
70. Nes, W. D., P. K. Hanners, and E. J. Parish. 1986. Inhibitors of fungal sterol C-24 alkylation: importance to developmental regulation. Biochem. Biophys. Res. Commun. 139:410-415.
71. O'Riordan, D. M., J. E. Standing, and A. H. Limper. 1995. Pneumocystis carinii glycoprotein A binds macrophage mannose receptors. Infect. Immun. 63:779-784.
72. O'Riordan, D. M., J. E. Standing, K. Y. Kwon, D. Chang, E. C. Crouch, and A. H. Limper. 1995. Surfactant protein D interacts with Pneumocystis carinii and mediates organism adherence to alveolar macrophages. J. Clin. Invest. 95:2699-2710.
73. Parish, E. J., P. K. Hanners, and W. D. Nes. 1987. Synthesis and biological evaluation of fungal bioregulators of sterol biosynthesis, p. 103-105. In P. K. Stumpf, J. B. Mudd, and W. D. Nes (ed.), The metabolism, structure and function of plant lipids. Plenum Press, New York, N.Y.
74. Paulsrud, J. R., T. P. Glancy, M. M. Shaw, M. S. Bartlett, and J. W. Smith. 1989. Fatty acid metabolism of Pneumocystis carinii in culture, abstr. 330, p. 246. In Abstracts of the 38th Annual Meeting of the American Society of Tropical Medicine and Hygiene 1989.
75. Paulsrud, J. R., S. F. Queener, M. S. Bartlett, and J. W. Smith. 1991. Total cellular fatty acid composition of cultured Pneumocystis carinii. J. Clin. Microbiol. 31:1899-1902.
76. Paulsrud, J. R., and S. F. Queener. 1994. Metabolism of fatty acids and amino acids by cultured Pneumocystis carinii, abstr. P15, p. 83. In Abstracts of the 47th Annual Meeting of the Society of Protozoologists 1994.
77. Paulsrud, J. R., and S. F. Queener. 1994. Metabolism of fatty acids and amino acids by cultured Pneumocystis carinii. J. Eukaryot. Microbiol. 41: 633-638.
78. Pesanti, E. L. 1987. Phospholipid profile of Pneumocystis carinii and its interaction with alveolar type II epithelial cells. Infect. Immun. 55:736-741.
79. Pesanti, E. L., and C. Cox. 1981. Metabolic and synthetic activities of Pneumocystis carinii in vitro. Infect. Immun. 34:908-914.
80. Phelps, D. S., and R. M. Rose. 1991. Increased recovery of surfactant protein A in AIDS-related pneumonia. Am. Rev. Respir. Dis. 143:1072-1075.
81. Pottratz, S. T., and W. J. Martin II. 1990. Role of fibronectin in Pneumocystis carinii attachment to cultured lung cells. J. Clin. Invest. 85:351-356.
82. Pottratz, S. T., J. Paulsrud, J. S. Smith, and W. J. Martin II. 1991. Pneumocystis carinii attachment to cultured lung cells by Pneumocystis gp120, a fibronectin binding protein. J. Clin. Invest. 88:403-407.
83. Racagni, G., M. G. de Lema, G. Hernandez, and E. E. Machado-Domenech. 1995. Fetal bovine serum induces changes in fatty acid composition of Trypanosoma cruzi phosphoinositides. Can. J. Microbiol. 41:951-954.
84. Rice, W. R., F. M. Singleton, M. J. Linke, and P. D. Walzer. 1993. Regulation of surfactant phosphatidylcholine secretion from alveolar type II cells during Pneumocystis carinii pneumonia in the rat. J. Clin. Invest. 92:2778-2899.
85. Rice, W. R., F. M. Singleton, M. J. Linke, and P. D. Walzer. 1993. Control of type II cell function by Pneumocystis carinii. Am. Rev. Respir. Dis. 147:A35.
86. Rodriguez, R. J., C. Low, C. D. K. Bottema, and L. W. Parks. 1985. Multiple functions for sterols in Saccharomyces cerevisiae. Biochim. Biophys. Acta 837:336-343.
87. Rose, R. M., P. J. Catalano, H. Koziel, and S. T. Furlong. 1994. Abnormal lipid composition of bronchoalveolar lavage fluid obtained from individuals with AIDS-related lung disease. Am. J. Respir. Crit. Care Med. 149:332-338.
88. Ross, P. F., P. E. Nelson, J. L. Richard, G. D. Oswiler, L. G. Rice, R. D. Plattner, and T. M. Wilson. 1990. Production of fumonisins by Fusarium moniliforme and Fusarium proliferatum isolates associated with equine leukoencephalomalacia and pulmonary edema syndrome in swine. Appl. Environ. Microbiol. 56:3225-3226.
89. Saric, M., and A. B. Clarkson, Jr. 1994. Ornithine decarboxylase in Pneumocystis carinii and implications for therapy. Antimicrob. Agents Chemother. 38:2545-2552.
90. 2 in experimental Pneumocystis carinii pneumonia. Am. Rev. Respir. Dis. 134:526-531.
91. Sleight, R. G., M. A. Mehta, and E. S. Kaneshiro. 1995. Uptake and metabolism of fluorescent lipid analogs by Pneumocystis carinii. J. Eukaryot. Microbiol. 41:111S.
92. Sloand, E., B. Laughon, M. Armstrong, M. S. Bartlett, W. Blumenfeld, M. Cushion, A. Kalica, J. A. Kovacs, W. Martin, E. Pitt, E. L. Pesanti, F. Richards, R. Rose, and P. Walzer. 1993. The challenge of Pneumocystis carinii culture. J. Eukaryot. Microbiol. 40:188-195.
93. Snyder, F. 1987. Platelet-activating factor and related lipid mediators. Plenum Press, New York, N.Y.
94. Sorice, M., L. Lenti, R. Misasi, C. Contini, L. Cignarella, T. Griggi, V. Vullo, and C. Masala. 1992. Evidence for the existence of ganglioside molecules on Pneumocystis carinii from human lungs. Parasitology 105:1-6.
95. Steinberg, R. I., J. A. Whitsett, W. M. Hull, and R. P. Baughman. 1995. Pneumocystis carinii alters surfactant protein A concentrations in bronchoalveolar lavage fluid. J. Lab. Clin. Med. 125:462-469.
96. Stimmler, M. M., F. P. Quismorio, Jr., W. G. McGehee, T. Boylen, and O. P. Sharma. 1989. Anticardiolipin antibodies in acquired immunodeficiency syndrome. Arch. Intern. Med. 149:1833-1835.
97. Stoll, L. L., and A. A. Spector. 1984. Changes in serum influences the fatty acid composition of established cell lines. In Vitro 20:732-738.
98. Stringer, J. R. 1996. Pneumocystis carinii: what is it, exactly? Clin. Microbiol. Rev. 9:489-498.
99. Stringer, J. R., and the Pneumocystis Workshop. 1994. Revised nomenclature for Pneumocystis carinii. J. Eukaryot. Microbiol. 41:121S-122S.
100. Stringer, J. R., S. L. Stringer, J. Zhang, R. Baughman, A. G. Smulian, and M. T. Cushion. 1993. Molecular genetic distinction of Pneumocystis carinii from rats and humans. J. Eukaryot. Microbiol. 40:733-741.
101. Stringer, S. L., J. R. Stringer, M. A. Blaise, P. D. Walzer, and M. T. Cushion. 1989. Pneumocystis carinii: sequence from ribosomal RNA implies a close relationship with fungi. Exp. Parasitol. 68:450-461.
102. Su, T. H., V. Natarajan, and W. J. Martin. 1992. Pulmonary surfactant in Pneumocystis carinii pneumonia is associated with a marked increase in sphingomyelin. Am. Rev. Respir. Dis. 145:A246.
103. Sul, D., and E. S. Kaneshiro. 1997. Ubiquinone synthesis by Pneumocystis carinii: incorporation of radiolabeled polyprenyl chain and benzoquinone ring precursors. J. Eukaryot. Microbiol. 44:60S. polyprenyl chain and the aromatic ring of ubiquinone. Unpublished data.
104. Thomas, J. R., M. J. McConville, J. E. Thomas-Oates, S. W. Homan, M. A. J. Ferguson, P. A. J. Gorin, K. D. Greis, and S. J. Turco. 1992. Refined structure of the lipophosphoglycan of Leishmania donovani. J. Biol. Chem. 267:6829-6833.
105. Tulloch, A. P. 1960. The oxygenated fatty acids of the oil of wheat stem rust uredospores. Can. J. Chem. 38:204-207.
106. Tulloch, A. P., B. M. Craig, and G. A. Ledingham. 1959. The oil of wheat stem rust uredospores. II. The isolation of cis-9,10-epoxyoctadecanoic acid, and the fatty acid composition of the oil. Can. J. Microbiol. 5:485-491.
107. 24(25) sterol methyl transferase inhibitors on Trypanosoma (Schizotrypanum) cruzi: in vitro and in vivo studies. Chemotherapy 42:294-307.
108. 24(25)-sterol methyl transferase inhibitors and their combinations with ketoconazole. Mol. Biochem. Parasitol. 79:199-210.
109. Walzer, P. D. 1993. Pneumocystis carinii pneumonia, 2nd ed. Marcel Dekker, Inc., New York, N.Y.
110. Weete, J. D. 1980. Lipid biochemistry of fungi and other organisms. Plenum Press, New York, N.Y.
111. Weete, J. D. 1989. Structure and function of sterols in fungi. Adv. Lipid Res. 23:484-491.
112. Weete, J. D., M. S. Sancholle, and C. Montant. 1983. Effects of triazoles on fungi. II. Lipid composition of Taphrina deformans. Biochim. Biophys. Acta 752:19-29.
113. Weete, J. D., M. S. Fuller, M. Q. Huang, and S. Gandhi. 1989. Fatty acids and sterols of selected hypochytriomycetes and chytridiomycetes. Exp. Mycol. 13:183-195.
114. Yardley, V., D. Snowdon, S. Croft, and B. Hazra. 1996. In vitro activity of diospyrin and derivatives against Leishmania donovani, Trypanosoma cruzi and Trypanosoma brucei brucei. Phytother. Res. 10:559-562.
115. Yoshikawa, H., H. Morioka, and Y. Yoshida. 1987. Freeze-fracture localization of filipin-sterol complexes in plasma- and cyto-membranes of Pneumocystis carinii. J. Protozool. 34:131-137.
116. Yoshikawa, H., and Y. Yoshida. 1988. Distribution of digitonin-sterol complexes in Pneumocystis carinii revealed by freeze-fracture method. Int. J. Parasitol. 18:39-45.
117. Zimmerman, P. E., D. R. Voelker, F. X. McCormack, and W. J. Martin. 1992. 120kDa surface glycoprotein of Pneumocystis carinii is a ligand for surfactant protein A. J. Clin. Invest. 89:143-149.